Efficacy of NNC0142-0002 in Subjects With Rheumatoid Arthritis (RA)

NCT01181050 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammation
Rheumatoid Arthritis

Interventions

DRUG: NNC0142-0002
DRUG: placebo

Sponsor

Janssen Research & Development, LLC